Freedom from Cancer Startup Challenge
  • Home
  • Winners
  • Overview
    • Key Dates
    • Phase 0 - Enter Challenge
    • Phase 1 - Elevator Speech
    • Phase 2 - Business Plan
    • Phase 3 - Start-up
  • Mavens
    • Ambassadors
    • Apply as Maven
  • About Us
    • Contact Us
    • Testimonials
    • News
    • Blog
  • Home
  • Winners
  • Overview
    • Key Dates
    • Phase 0 - Enter Challenge
    • Phase 1 - Elevator Speech
    • Phase 2 - Business Plan
    • Phase 3 - Start-up
  • Mavens
    • Ambassadors
    • Apply as Maven
  • About Us
    • Contact Us
    • Testimonials
    • News
    • Blog
Search by typing & pressing enter

YOUR CART

RETURN TO ALL INVENTIONS LIST
RETURN TO DIAGNOSTICS LIST
RETURN TO THERAPEUTICS LIST
Calcium phosphate nanowhisker particles, method of making and using the same
Patent Number: US8906415

Executive Summary:
  • Invention Type: Diagnostic/Therapeutic
  • Patent Status: Active
  • Patent Link: https://patents.google.com/patent/US8906415
  • Research Institute: University of Toledo
  • Disease Focus: Cancer
  • Basis of Invention: A calcium phosphate nanowhisker particle having a high aspect ratio.
  • How it works: A method of diagnosing genitourinary cancers based on thromboxane receptor β (TPβ) levels in liquid samples, as well as a kit for this diagnostic tool. This is a more sensitive and more specific early detection tool
  • Lead Challenge Inventor: Sarit Bhaduri
  • Inventors: Sarit Bhaduri, Darcy E. Wagner
  • Development Stage: Pre-clinical, Validation of the lead peptide in xenograft mouse model
  • Novelty:
    • Improved nanoparticle formulation for localized, less toxic active agent delivery 
  • Clinical Applications:
    • Can be used for localized, less toxic chemotherapy delivery

General Description:
A process for forming a calcium phosphate nanowhisker particle, comprising:
i) exposing a mixture of a soluble calcium, a soluble phosphate, and urea to microwave energy for a predetermined period of time and at a predetermined energy level sufficient to cause an exothermic reaction; and thereafter,
ii) cooling the mixture of step i) so that calcium phosphate nanowhiskers having a length:diameter aspect ratio of greater than about 1:1 are precipitated in a molten salt bath, wherein
the mixture comprises an aqueous solution of Ca(NO3)2 and an aqueous solution of KH2PO4 at a ratio of about 1:0.38, by weight.

Strengths:
The nanowhisker particles are stable, provide immediate and sustained release, are biocompatible, biodegradable, and have non-toxic and non-acidic degradation products

Weaknesses:
  • Other groups are developing calcium nanoparticles for drug delivery

Patent Status:
  • Filing date – 2012-10-26
  • Publication date – 2014-12-09
  • Grant date – 2014-12-09

Inventor Bio: Sarit Bhaduri
http://www.eng.utoledo.edu/mime/faculty_staff/faculty/sbhaduri/
Powered by Create your own unique website with customizable templates.